AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
BERACTANT
11 registrations across 4 African markets— 9 active
Markets with BERACTANT
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| SURVANTA | 🇬🇭Ghana | — | active | May 2030 |
| SURVANTA | 🇬🇭Ghana | — | active | May 2030 |
| SURVANTA | 🇬🇭Ghana | — | active | Mar 2030 |
| SURVANTA | 🇬🇭Ghana | — | active | Mar 2030 |
| SURVANTA Susp. p. instill endotrachéobronchique / 100mg/4ml | 🇹🇳Tunisia | ABBVIE CORPORATION | expired | Jun 2018 |
| SURVANTA Susp. p. instill endotrachéobronchique / 200mg/8ml | 🇹🇳Tunisia | ABBVIE CORPORATION | expired | Jun 2018 |
| BERACTANT TOPICAL EXTERNAL
INSTILLATION VIALS | 🇺🇬Uganda | ABBVIE (PTY) LTD | active | — |
| BERACTANT TOPICAL
EXTERNAL
INSTILLATION
VIALS | 🇺🇬Uganda | ABBVIE (PTY) LTD | active | — |
| BERACTANT TOPICAL
EXTERNAL
INSTILLATION
VIALS | 🇺🇬Uganda | ABBVIE (PTY) LTD | active | — |
| SURVANTA Suspension, Oral | 🇹🇿Tanzania | Abbvie (Pty) Limited | active | — |
| BERACTANT TOPICAL EXTERNAL
INSTILLATION VIALS | 🇺🇬Uganda | ABBVIE (PTY) LTD | active | — |
BERACTANT in Africa — Regulatory Overview
BERACTANT is registered across 4 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Ghana, Uganda, Tunisia, Tanzania. AfricaRegulatory refreshes this data daily from official government sources.
Of the 11 registrations, 9 (82%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.